drugset / Trial / NCT03306836

Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2

NCT03306836

RandomizedParallel-groupSingle-blindTreatment

Summary

In the stage of randomized controlled study, our purpose is to obtain the Intraoperative anticoagulation program supported by evidence-based medicine.

Timeline

Start
2016-09
Primary completion
2020-09
Completion
2021-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 18 iu/kg